Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.

Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.

Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8.

2.

Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.

Huntley JF, Conley PG, Rasko DA, Hagman KE, Apicella MA, Norgard MV.

Infect Immun. 2008 Aug;76(8):3664-71. doi: 10.1128/IAI.00374-08. Epub 2008 May 27.

3.

Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.

Trzciński K, Thompson CM, Srivastava A, Basset A, Malley R, Lipsitch M.

Infect Immun. 2008 Jun;76(6):2678-84. doi: 10.1128/IAI.00141-08. Epub 2008 Apr 7.

4.

Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.

Rawool DB, Bitsaktsis C, Li Y, Gosselin DR, Lin Y, Kurkure NV, Metzger DW, Gosselin EJ.

J Immunol. 2008 Apr 15;180(8):5548-57.

5.

Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.

Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.

Microbiol Immunol. 2008 Feb;52(2):55-63. doi: 10.1111/j.1348-0421.2008.00010.x.

6.

Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.

Bublin M, Hoflehner E, Wagner B, Radauer C, Wagner S, Hufnagl K, Allwardt D, Kundi M, Scheiner O, Wiedermann U, Breiteneder H.

Vaccine. 2007 Dec 5;25(50):8395-404. Epub 2007 Oct 22.

PMID:
17997199
7.

Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity.

Lavine CL, Clinton SR, Angelova-Fischer I, Marion TN, Bina XR, Bina JE, Whitt MA, Miller MA.

Eur J Immunol. 2007 Nov;37(11):3007-20.

8.

Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.

Lu Z, Roche MI, Hui JH, Unal B, Felgner PL, Gulati S, Madico G, Sharon J.

Immunol Lett. 2007 Oct 15;112(2):92-103. Epub 2007 Aug 8.

9.

Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.

Basset A, Thompson CM, Hollingshead SK, Briles DE, Ades EW, Lipsitch M, Malley R.

Infect Immun. 2007 Nov;75(11):5460-4. Epub 2007 Aug 13.

10.

Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.

Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW.

J Immunol. 2007 Jul 1;179(1):532-9.

11.
13.

Mouse model of oral infection with virulent type A Francisella tularensis.

KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, Chen W.

Infect Immun. 2007 Apr;75(4):1651-60. Epub 2007 Jan 22.

14.

Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis.

Malik M, Bakshi CS, McCabe K, Catlett SV, Shah A, Singh R, Jackson PL, Gaggar A, Metzger DW, Melendez JA, Blalock JE, Sellati TJ.

J Immunol. 2007 Jan 15;178(2):1013-20.

16.
17.

Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.

Luci C, Hervouet C, Rousseau D, Holmgren J, Czerkinsky C, Anjuère F.

J Immunol. 2006 Mar 1;176(5):2749-57.

18.

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M.

Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53. Epub 2005 Mar 21.

19.

Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.

Green M, Choules G, Rogers D, Titball RW.

Vaccine. 2005 Apr 8;23(20):2680-6.

PMID:
15780452

Supplemental Content

Support Center